Osimertinib for EGFR-mutant lung cancer
Автор: VJOncology
Загружено: 2020-11-06
Просмотров: 6458
Описание: Jarushka Naidoo, MBBCh, Beaumont Hospital, Dublin, Ireland, outlines the approval and reimbursement of osimertinib in patients with EGFR mutant non-small cell lung cancer, based on the results of the FLAURA study. (NCT02296125). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology)
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: